Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum]
Xue H, Yu Z, Liu Y, et al. Int J Nanomedicine.2017;12:5271–5287. The authors of this paper have advised that Figure 8E is incorrect. Because of the similar label of groups LHD/miR-375 and LH/miR-375, the authors uploaded the wrong figure by mistake. The authors have confi...
Guardado en:
Autores principales: | Xue H, Yu Z, Liu Y, Yuan W, Yang T, You J, He X, Lee RJ, Li L, Xu C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/af63fabb28d740568236a29627b844f1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma
por: Xue H, et al.
Publicado: (2017) -
Fabricating polydopamine-coated MoSe2-wrapped hollow mesoporous silica nanoplatform for controlled drug release and chemo-photothermal therapy
por: Chai S, et al.
Publicado: (2018) -
Mesoporous Silica Nanoparticle-Based Imaging Agents for Hepatocellular Carcinoma Detection
por: Xuqi Peng, et al.
Publicado: (2021) -
Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release
por: Hakeem A, et al.
Publicado: (2018) -
Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy
por: Li Y, et al.
Publicado: (2018)